Pirfenidone ameliorates pulmonary inflammation and fibrosis in a rat silicosis model by inhibiting macrophage polarization and JAK2/STAT3 signaling pathways.
Tang Q, Xing C, Li M, Jia Q, Bo C, Zhang Z.
Ecotoxicol Environ Saf. 2022 Oct 1;244:114066. doi: 10.1016/j.ecoenv.2022.114066. Epub 2022 Sep 13.
PMID:36108436
Lung cancer risk and occupational pulmonary fibrosis: systematic review and meta-analysis.
Krabbe J, Steffens KM, Drießen S, Kraus T.
Eur Respir Rev. 2024 Feb 14;33(171):230224. doi: 10.1183/16000617.0224-2023. Print 2024 Jan 31.
PMID:38355151
Pulmonary osteoclast-like cells in silica induced pulmonary fibrosis.
Hasegawa Y, Franks JM, Tanaka Y, Uehara Y, Read DF, Williams C, Srivatsan S, Pitstick LB, Nikolaidis NM, Shaver CM, Kropski J, Ware LB, Taylor CJ, Banovich NE, Wu H, Gardner JC, Osterburg AR, Yu JJ, Kopras EJ, Teitelbaum SL, Wikenheiser-Brokamp KA, Trapnell C, McCormack FX.
Dioscin Alleviates Crystalline Silica-Induced Pulmonary Inflammation and Fibrosis through Promoting Alveolar Macrophage Autophagy.
Du S, Li C, Lu Y, Lei X, Zhang Y, Li S, Liu F, Chen Y, Weng D, Chen J.
Theranostics. 2019 Mar 7;9(7):1878-1892. doi: 10.7150/thno.29682. eCollection 2019.
PMID:31037145
Fibroblast-derived CXCL14 aggravates crystalline silica-induced pulmonary fibrosis by mediating polarization and recruitment of interstitial macrophages.